<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-038136</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Statistical study and clinical results by comparison of two different protocols in the treatment of sudden hearing loss</dc:title>
<dc:description xml:lang="en">Sudden deafness goes on being a clinical entity of unknown cause for which several theories and treatments have been proposed. We are reporting a comparative study of two different protocols that we have performed on 60 patients (divided in two groups of 30) diagnosed and admitted with sudden hearing loss between 1989 and 2003. The main goal is to prove if there is a statistical and significant difference among both, in respect of the audiologic improvement obtained, after two weeks of therapy at east. We have applied the normal approximation of Mann-Whitney's test and we can argue, after its result, our current protocol (piracetam, pentoxifiline, metilprednisolone), which includes 4 days of endovenous treatment another 10 days at home. The presence of vestibular symptoms darkens the prognosis since about 95% of the patients with them have not improved significantly (p&lt;0.05)</dc:description>
<dc:creator>Pantoja Hernández, CG</dc:creator>
<dc:creator>Trinidad Ruiz, G</dc:creator>
<dc:creator>González Palomino, A</dc:creator>
<dc:creator>Montero García, C</dc:creator>
<dc:creator>Pardo Romero, G</dc:creator>
<dc:creator>Blasco Huelva, A</dc:creator>
<dc:creator>Pino Rivero, V</dc:creator>
<dc:creator>Marcos García, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La sordera súbita continúa siendo una entidad clínica de etiología desconocida para la cual se han propuesto diversas teorías y tratamientos. Presentamos un estudio comparativo de dos protocolos diferentes que hemos utilizado en 60 pacientes (divididos en dos grupos de 30) diagnosticados e ingresados por hipoacusia brusca entre los años 1989 y 2003. El objetivo principal es comprobar si existe diferencia estadísticamente significativa entre ambos, respecto a la mejoría auditiva obtenida, tras al menos dos semanas de tratamiento. Aplicamos la aproximación normal de la prueba de Mann-Whitney y defendemos, tras su resultado, nuestro protocolo actual (piracetam, pentoxifilina,metilprednisolona), que comprende 4 días de tratamiento intravenoso y 10 más de tratamiento domiciliario. La presencia de síntomas vestibulares asociados ensombrece el pronóstico pues casi el 95% de los pacientes que los presentaban no experimentaron recuperación significativa (p&lt;0,05)</dc:description>
<dc:source>Acta Otorrinolaringol Esp;56(2): 63-67, feb. 2005. tab</dc:source>
<dc:identifier>ibc-038136</dc:identifier>
<dc:title xml:lang="es">Estudio estadístico y resultados clínicos de la comparación de dos protocolos diferentes en el tratamiento de la hipoacusia brusca</dc:title>
<dc:subject>^d906^s22073</dc:subject>
<dc:subject>^d4871^s22073</dc:subject>
<dc:subject>^d6470^s22080</dc:subject>
<dc:subject>^d27977</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22562^s22000</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d4418^s22083</dc:subject>
<dc:subject>^d11322^s22073</dc:subject>
<dc:subject>^d6470^s22057</dc:subject>
<dc:subject>^d22562^s22073</dc:subject>
<dc:subject>^d6470^s22016</dc:subject>
<dc:subject>^d11718^s22073</dc:subject>
<dc:subject>^d906^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>200502</dc:date>
</metadata>
</record>
</ibecs-document>
